This site uses cookies, including third-party cookies, that help us to provide and improve our services.

Privacy Policy
- Global Locations -
Headquarters
Future Market Insights, Inc.
Christiana Corporate, 200 Continental Drive, Suite 401, Newark, Delaware - 19713, United States
T: +1-845-579-5705
MEA
Market Access DMCC
1602-6 Jumeirah Bay X2 Tower, Plot No: JLT-PH2-X2A,
Jumeirah Lakes Towers, Dubai,
United Arab Emirates
Americas
Future Market Insights
616 Corporate Way, Suite 2-9018,
Valley Cottage, NY 10989,
United States
T: +1-347-918-3531
Europe
Future Market Insights
3rd Floor, 207 Regent Street,
London W1B 3HH
United Kingdom
T: + 44 (0) 20 8123 9659
D: +44 (0) 20 3287 4268
APAC
Future Market Insights
Office No. 401-A, 4th Floor,
VANTAGE 9, S.No. 36/1/1,
Baner, Pune 411045 India

Oncology Nutrition Market

Uncover How Oncology Nutrition is Still a Crucial Topic of Attention for Healthcare Professionals with FMI

Oncology Nutrition Market by Cancer Type, End Use & Region - Forecast 2022 - 2032

Oncology Nutrition Market Size - Industry Outlook (2022-2032)

The oncology nutrition market Size is projected to be valued at US$ 2.04 Bn in 2022 and is expected to be valued at US$ 4.79 Bn by 2032. The demand for oncology nutrition is likely to grow at an average CAGR of 8.9% during the forecast period. T

Oncology nutrition formulas have a lot of room to expand due to factors including the creation of elemental formulations and product innovation in terms of non-GMO-based formulas. The demand for oncology nutrition is expanding due to the factors like the shift in emphasis from parenteral to enteral nutrition, rising cancer incidence, rising demand for nutritional feeding in the homecare industry, rising numbers of patients receiving treatment for malnutrition, and improving quality of clinical research on nutritional interventions.

The oncology nutrition market share is anticipated to expand significantly over the next few years due to technological developments and extensive research. Due to the worldwide increase in cases of malnutrition brought on by tumors, oncology nutrition is still a crucial topic for healthcare professionals.

Report Attribute

Details

Oncology Nutrition Market Value (2022)

US$ 2.04 Bn

Market Anticipated Forecast Value (2032)

US$ 4.79 Bn

Market Projected Growth Rate (2022-2032)

8.9%

Oncology nutrition is crucial for enhancing physical capacity, coping with cancer therapies, and overall quality of life. For businesses functioning in the contemporary oncology nutrition industry, the fall in tolerance to cancer therapy is anticipated to boost the adoption of oncology nutrition. Furthermore, nutritional screening and evaluation are essential for identifying people who are more likely to be malnourished. According to several studies, malnutrition screening in cancer treatment will enhance nutritional evaluation and help patients avoid malnutrition. The demand for oncology nutrition is anticipated to pick up steam throughout the evaluation period, even if the nutritional risk is still mostly beneath the radar.

Customize this Report

Let us know your requirement to get
100% FREE customization

What are the Key Oncology Nutrition Market Dynamics?

Growth Driving Factors in the Oncology Nutrition Market

A significant driver of the oncology nutrition market's growth is projected to be the huge increase in nutritional waste and nutritional risk among cancer patients. Participants in the market landscape are now investigating the possible advantages of utilizing a multidisciplinary strategy, where focused nutrition is expected to be crucial to improving the standard of cancer care. A few key aspects anticipated to drive the expansion of the market for oncology nutrition in the upcoming years include:

  • Evolving recommendations.
  • A rise in observational studies.
  • An increase in the number of clinical trials globally.

Due to these factors, The global oncology nutrition market is anticipated to reach US$ 3.12 billion by the end of 2027.

The oncology nutrition market is anticipated to profit from increased research and development activities as well as the launch of cutting-edge products for cancer patients over the forecasted period. The creation of essential formulas and the advent of new markets are also anticipated to boost the adoption of oncology nutrition and the pace of future expansion.

Due to the considerable increase in the use of nutritional evaluation programs, particularly during cancer cachexia and precachexia, the demand for oncology nutrition is predicted to continue to rise. Over the past ten years, data gathering methods for varied patients' nutritional status have advanced quickly. These developments have led to personalized oncology nutrition therapy and are now recognized as the perfect remedy for cancer patients prone to malnutrition.

Challenges and Factors Influencing the Oncology Nutrition Market Growth

  • As cancer patients keep increasing, several nations are dealing with significant healthcare difficulties. About 85% of cancer cases globally, in the opinion of many medical professionals, are related to poor nutrition and a sedentary lifestyle.
  • The development pace of the oncology nutrition market is likely to be slowed by issues with tube feeling. The poor reimbursement for its usage is likely to hinder the growth of the market for oncology nutrition. Lack of understanding is anticipated to be a new challenge for the oncology nutrition market over the forecast period.
  • The insufficient and ambiguous recommendations established by authoritative authorities, as a result of which oncology nutrition stayed at the backseat, is one of the most significant issues that market participants in the oncology nutrition industry have had to cope with over several decades.
Sabyasachi Ghosh
Principal Consultant
LinkedIn
Talk to Analyst

Find your sweet spots for generating winning opportunities in this market.

Talk to Analyst

Key Trends Governing the Oncology Nutrition Market During 2022-2032

  • The oncology nutrition market is growing primarily as a result of the growth in cancer prevalence. Another significant factor influencing the oncology nutrition market's growth rate is the rising cost of healthcare.
  • The adoption of oncology nutrition is also anticipated to develop due to improvements in fundamental methods, growing government funding, and rising public and private sector initiatives to increase knowledge of cancer patient nutrition.
  • Contrarily, obesity and food are to blame for 35% and 30%, respectively, of all cancer-related mortality. Eating a lot of nutritious meals might help cancer patients increase their strength and stamina throughout treatment. Because they help stop cancer cells from proliferating, nutrient-rich meals are in more demand.

Comparative View of Adjacent Oncology Nutrition Market

Oncology Nutrition Market:

Attributes

Oncology Nutrition Market

CAGR (2022 - 2032)

8.9%

Oncology Nutrition Market Value (2026)

US$ 2.88 billion

Growth Factor

The rising need for nutritional goods for home care.

Opportunity

The need to fulfil the nutritional requirements of cancer patients is escalating.

Key Trends

The transition from parenteral to enteral nutrition, expanding cancer incidence, and growing demand for nutritional requirements are all driving market expansion.

Interventional Oncology Market:

Attributes

Interventional Oncology Market

CAGR (2022 - 2032)

6.9%

Oncology Nutrition Market Value (2026)

US$ 2.9 billion

Growth Factor

The key factors driving the growth of the interventional oncology market are technological improvements and the increased prevalence of oncology.

Opportunity

The interventional oncology market has a lot of room for expansion for both established and new product companies.

Key Trends

In several emerging economies, such as China, India, Brazil, and Mexico, rapid economic development and rising healthcare spending are projected to enhance access to high-quality healthcare.

Nutritional Analysis Market:

Attributes

Nutritional Analysis Market

CAGR (2022 - 2032)

8.5%

Oncology Nutrition Market Value (2026)

US$ 7.9 billion

Growth Factor

Shifting consumer tastes, greater health awareness, the growing millennial population, and a growth in supplemental income among consumers are all driving the industry.

Opportunity

The market for nutritional analysis will benefit from the rising favorable attitude on sports nutrition.

Key Trends

The need for nutritional analysis is being driven by changing lifestyles and a high frequency of chronic illnesses.

Other variables that are likely to affect the oncology nutrition market's growth rate favourably include a rise in demand for nutritional food from the homecare sector and a lifestyle change. In addition, an increase in the number of clinical studies, quick product development, and a greater focus on enteral nutrition is likely to cushion the oncology nutrition market's growth.

Furthermore, the presence of competitors, new product debuts, and partnerships related to the industry under consideration all contribute to the market's growth. According to the report, Esperer launched its nutrition development center in Hyderabad in 2020. The facility in Hyderabad is expected to house a variety of cohesive capabilities, such as investigative workrooms and product development sub-centres, with a dedicated laboratory for analyzing sensory components, packing, and taste.

Become a MarketNgage Insider

An unified Market Research Subscription Platform, built for today’s disparate research needs.

Segmentation Outlook for the Oncology Nutrition Market

Lung Cancer Segment is Predicted to Lead the Oncology Nutrition Market By Cancer Type Throughout the Forecast Period

The lung cancer sector is expected to develop over the research period due to the high incidence of lung cancer in the global population, growth in lung cancer nutritional supplements, and increased awareness and importance of nutritional supplement use. As the number of individuals diagnosed with cancer rises, so does the demand for oncology nutrition because diet provides the ability to fight disease and provides power and endurance against the treatment's side effects.

Regional Analysis of the Oncology Nutrition Market

North America Oncology Nutrition Market Outlook

North America is anticipated to lead the global oncology nutrition market throughout the forecast period. This is due to a number of important factors, including the increased incidence of cancer and the accessibility of cutting-edge healthcare infrastructure. The oncology nutrition market in the United States is expected to be worth US$ 412.6 million. The U.S. presently holds 35.62% of the global oncology nutrition market share. Demand for oncology nutrition is predicted to increase in the United States, fueled by rising spending on various cancer medicines.

According to a statistic from the American Cancer Society, there will likely be 1.9 million new instances of cancer in the U.S. this year. Government programs, new product introductions, and partnerships in the field of cancer nutrition supplements all contribute to market expansion. For instance, the "2022 Oncology Nutrition Symposium" was held in June 2022 by the Academy of Nutrition and Dietetics.

Asia Pacific to Witness High Growth Potential in the Oncology Nutrition Market

FMI projects that the Asia Pacific oncology nutrition market is anticipated to expand faster due to the region's rising prevalence of cancer cases. Additionally, several certification programs and awareness sessions are held locally to inform cancer patients and healthcare professionals about the significance of oncology nutrition.

Combined Regional Insights of Oncology Nutrition Market

  • By 2026, the second-largest economy in the world, China, is anticipated to have an oncology nutrition market of US$165 million, indicating a CAGR of 10.6% over the duration of the research.
  • Other significant geographic oncology nutrition markets include Japan and Canada, with growth rates of 7.4% and 7.1%, respectively, predicted for the projected period.
  • China is projected to keep being one of the countries with the quickest rate of growth in the APAC oncology nutrition market. Latin America is anticipated to expand at a 7.6% CAGR over the course of the study period, while the Asia Pacific oncology nutrition market is anticipated to reach US$19.2 million, driven by countries like Australia, India, and South Korea.
  • The European oncology nutrition market is anticipated to reach US$182.4 million, with Germany seeing an annual growth rate of 8.4%.

Startup Ecosystem

With certain major pharmaceutical corporations, startups in the oncology nutrition sector are working hard in this area. Clinical studies now include parenteral oncology feeding. Oncology nutrition is projected to become more popular as cancer incidence rises along with the demand for tailored medication and nutrition. In the market for cancer nutrition, this is anticipated to present considerable prospects for companies.

For instance, the American biotechnology giant Celgene Corporation teamed up with Savor Health, a provider of specialized nutritional advice to cancer patients.

Competitive Landscape of the Oncology Nutrition Market

New product launches and continuous technological innovations are the key strategies adopted by the major players in the oncology nutrition market. The healthcare systems organizations are changing due to new research and increased public knowledge of the advantages of oncology nutrition. Clinical nutritionists and oncologists are working more closely to improve oncology nutrition and oncology treatment within the oncology nutrition sector.

The leading firms worldwide for oncology nutrition are focused on obtaining regulatory clearances, developing cutting-edge goods, introducing new products, and partnering and acquiring other businesses. The global market for oncology nutrition is projected to expand due to these leading players' tactics. The following are a few expansion methods used by companies in the oncology nutrition market:

  • To increase its presence in medical nutrition, Nestle acquired the Allergan business in January 2020.
  • Smartfish AS and B. Braun worked together to introduce Remune, a medicinal nutrition solution, in September 2019. In 2019 and 2020, B. Braun introduced Remune in over 20 nations. Several other markets in Europe, Asia, and South America followed.
  • Ina, the intelligent nutrition helper, was introduced by CancerCare in collaboration with Savor Health in 2019. The Ina offers tailored, evidence-based nutrition counseling to help cancer patients eat well and stay fed during treatment.
  • A three-chamber bag with a unique protein-to-energy ratio called mofKabiven additional Nitrogen was introduced by Fresenius Kabi AG in 2018 in Europe.
  • The "SmartPN" tool was introduced in October 2018 by Baxter International Inc. and the American Society for Parenteral and Enteral Nutrition (ASPEN) to reduce clinical malnutrition.

Key Players in the Oncology Nutrition Market

  • FMC Corporation
  • Danone India
  • Abbott
  • Aceto
  • B. Braun Melsungen AG
  • Baxter
  • Fresenius Kabi AG
  • Global Health Products, Inc.
  • Hormel Foods Corporation
  • Mead Johnson & Company, LLC
  • Meiji Holdings Co., Ltd
  • Nestlé S.A.
  • BioSig Technologies, Inc.
  • Auris Health, Inc.

Scope of the Report

Attribute

Details

Growth Rate

CAGR of 8.9 from 2022 to 2032

Base Year of Estimation

2022

Historical Data

2017-2021

Forecast Period

2022-2032

Quantitative Units

Revenue in US$ Mn and F-CAGR from 2022-2032

Report Coverage

Revenue Forecast, Volume Forecast, Company Ranking, Competitive Landscape, growth factors, Trends and Pricing Analysis

Key Segments Covered

  • By Cancer Type
  • By End Use
  • By Region

Regions Covered

  • North America
  • Latin America
  • Europe
  • East Asia
  • South Asia
  • Middle East & Africa
  • Oceania

Key Countries Profiled

  • U.S.
  • Canada
  • Brazil
  • Mexico
  • Germany
  • Italy
  • France
  • U.K.
  • Spain
  • Russia
  • China
  • Japan
  • India
  • GCC Countries
  • Australia

Key Companies Profiled

  • FMC Corporation
  • Danone India
  • Abbott
  • Aceto
  • B. Braun Melsungen AG
  • Baxter
  • Fresenius Kabi AG
  • Global Health Products, Inc.
  • Hormel Foods Corporation
  • Mead Johnson & Company, LLC
  • Meiji Holdings Co., Ltd
  • Nestlé S.A.
  • BioSig Technologies, Inc.
  • Auris Health, Inc.

KEY SEGMENTS

By Cancer Type:

  • Head & Neck Cancer
  • Stomach & Gastrointestinal Cancers
  • Blood Cancer
  • Breast Cancer
  • Lung Cancer
  • Other cancers

By End Use:

  • Hospitals
  • Home Care
  • Others

By Region:

  • North America
    • US
    • Canada
  • Europe
    • Germany
    • France
    • UK
    • Italy
    • Spain
    • Rest of Europe (RoE)
  • Asia Pacific
  • Latin America
  • Middle East and Africa

Frequently Asked Questions

The oncology nutrition market is projected to grow at a CAGR of 8.9% during the forecast period.

The oncology nutrition market is expected to be valued at US$ 4.79 Bn by 2032.

The hospital segment is predicted to have the greatest oncology nutrition market share.

By 2032, the highest oncology nutrition market share is predicted to be occupied by North America.

Table of Content

1. Executive Summary

    1.1. Global Market Outlook

    1.2. Demand-side Trends

    1.3. Supply-side Trends

    1.4. Technology Roadmap Analysis

    1.5. Analysis and Recommendations

2. Market Overview

    2.1. Market Coverage / Taxonomy

    2.2. Market Definition / Scope / Limitations

3. Market Background

    3.1. Market Dynamics

        3.1.1. Drivers

        3.1.2. Restraints

        3.1.3. Opportunity

        3.1.4. Trends

    3.2. Scenario Forecast

        3.2.1. Demand in Optimistic Scenario

        3.2.2. Demand in Likely Scenario

        3.2.3. Demand in Conservative Scenario

    3.3. Opportunity Map Analysis

    3.4. Product Life Cycle Analysis

    3.5. Supply Chain Analysis

        3.5.1. Supply Side Participants and their Roles

            3.5.1.1. Producers

            3.5.1.2. Mid-Level Participants (Traders/ Agents/ Brokers)

            3.5.1.3. Wholesalers and Distributors

        3.5.2. Value Added and Value Created at Node in the Supply Chain

        3.5.3. List of Raw Material Suppliers

        3.5.4. List of Existing and Potential Buyer’s

    3.6. Investment Feasibility Matrix

    3.7. Value Chain Analysis

        3.7.1. Profit Margin Analysis

        3.7.2. Wholesalers and Distributors

        3.7.3. Retailers

    3.8. PESTLE and Porter’s Analysis

    3.9. Regulatory Landscape

        3.9.1. By Key Regions

        3.9.2. By Key Countries

    3.10. Regional Parent Market Outlook

    3.11. Production and Consumption Statistics

    3.12. Import and Export Statistics

4. Global Oncology Nutrition Analysis 2017-2021 and Forecast, 2022-2032

    4.1. Historical Market Size Value (US$ Bn) Analysis, 2017-2021

    4.2. Current and Future Market Size Value (US$ Bn) Projections, 2022-2032

        4.2.1. Y-o-Y Growth Trend Analysis

        4.2.2. Absolute $ Opportunity Analysis

5. Global Oncology Nutrition Analysis 2017-2021 and Forecast 2022-2032, By Cancer Type

    5.1. Introduction / Key Findings

    5.2. Historical Market Size Value (US$ Bn) Analysis By Cancer Type, 2017-2021

    5.3. Current and Future Market Size Value (US$ Bn) Analysis and Forecast By Cancer Type, 2022-2032

        5.3.1. Head & Neck

        5.3.2. Stomach & Gastrointestinal

        5.3.3. Pancreatic

        5.3.4. Breast

        5.3.5. Liver

        5.3.6. Other Cancer Types

    5.4. Y-o-Y Growth Trend Analysis By Cancer Type, 2017-2021

    5.5. Absolute $ Opportunity Analysis By Cancer Type, 2022-2032

6. Global Oncology Nutrition Analysis 2017-2021 and Forecast 2022-2032, By End-Use

    6.1. Introduction / Key Findings

    6.2. Historical Market Size Value (US$ Bn) Analysis By End-Use, 2017-2021

    6.3. Current and Future Market Size Value (US$ Bn) Analysis and Forecast By End-Use, 2022-2032

        6.3.1. Hospitals

        6.3.2. Home Care

        6.3.3. Other End-Uses

    6.4. Y-o-Y Growth Trend Analysis By End-Use, 2017-2021

    6.5. Absolute $ Opportunity Analysis By End-Use, 2022-2032

7. Global Oncology Nutrition Analysis 2017-2021 and Forecast 2022-2032, By Region

    7.1. Introduction

    7.2. Historical Market Size Value (US$ Bn) Analysis By Region, 2017-2021

    7.3. Current Market Size Value (US$ Bn) Analysis and Forecast By Region, 2022-2032

        7.3.1. North America

        7.3.2. Latin America

        7.3.3. Europe

        7.3.4. Asia Pacific

        7.3.5. MEA

    7.4. Market Attractiveness Analysis By Region

8. North America Oncology Nutrition Analysis 2017-2021 and Forecast 2022-2032, By Country

    8.1. Historical Market Size Value (US$ Bn) Trend Analysis By Market Taxonomy, 2017-2021

    8.2. Market Size Value (US$ Bn) Forecast By Market Taxonomy, 2022-2032

        8.2.1. By Country

            8.2.1.1. U.S.

            8.2.1.2. Canada

        8.2.2. By Cancer Type

        8.2.3. By End-Use

    8.3. Market Attractiveness Analysis

        8.3.1. By Country

        8.3.2. By Cancer Type

        8.3.3. By End-Use

    8.4. Key Takeaways

9. Latin America Oncology Nutrition Analysis 2017-2021 and Forecast 2022-2032, By Country

    9.1. Historical Market Size Value (US$ Bn) Trend Analysis By Market Taxonomy, 2017-2021

    9.2. Market Size Value (US$ Bn) Forecast By Market Taxonomy, 2022-2032

        9.2.1. By Country

            9.2.1.1. Brazil

            9.2.1.2. Mexico

            9.2.1.3. Argentina

            9.2.1.4. Chile

            9.2.1.5. Peru

            9.2.1.6. Rest of Latin America

        9.2.2. By Cancer Type

        9.2.3. By End-Use

    9.3. Market Attractiveness Analysis

        9.3.1. By Country

        9.3.2. By Cancer Type

        9.3.3. By End-Use

    9.4. Key Takeaways

10. Europe Oncology Nutrition Analysis 2017-2021 and Forecast 2022-2032, By Country

    10.1. Historical Market Size Value (US$ Bn) Trend Analysis By Market Taxonomy, 2017-2021

    10.2. Market Size Value (US$ Bn) Forecast By Market Taxonomy, 2022-2032

        10.2.1. By Country

            10.2.1.1. Germany

            10.2.1.2. Italy

            10.2.1.3. France

            10.2.1.4. U.K.

            10.2.1.5. Spain

            10.2.1.6. Russia

            10.2.1.7. BENELUX

            10.2.1.8. Rest of Europe

        10.2.2. By Cancer Type

        10.2.3. By End-Use

    10.3. Market Attractiveness Analysis

        10.3.1. By Country

        10.3.2. By Cancer Type

        10.3.3. By End-Use

    10.4. Key Takeaways

11. Asia Pacific Oncology Nutrition Analysis 2017-2021 and Forecast 2022-2032, By Country

    11.1. Historical Market Size Value (US$ Bn) Trend Analysis By Market Taxonomy, 2017-2021

    11.2. Market Size Value (US$ Bn) Forecast By Market Taxonomy, 2022-2032

        11.2.1. By Country

            11.2.1.1. China

            11.2.1.2. Japan

            11.2.1.3. South Korea

            11.2.1.4. Rest of Asia Pacific

        11.2.2. By Cancer Type

        11.2.3. By End-Use

    11.3. Market Attractiveness Analysis

        11.3.1. By Country

        11.3.2. By Cancer Type

        11.3.3. By End-Use

    11.4. Key Takeaways

12. MEA Oncology Nutrition Analysis 2017-2021 and Forecast 2022-2032, By Country

    12.1. Historical Market Size Value (US$ Bn) Trend Analysis By Market Taxonomy, 2017-2021

    12.2. Market Size Value (US$ Bn) Forecast By Market Taxonomy, 2022-2032

        12.2.1. By Country

            12.2.1.1. GCC Countries

            12.2.1.2. South Africa

            12.2.1.3. Turkey

            12.2.1.4. Rest of MEA

        12.2.2. By Cancer Type

        12.2.3. By End-Use

    12.3. Market Attractiveness Analysis

        12.3.1. By Country

        12.3.2. By Cancer Type

        12.3.3. By End-Use

    12.4. Key Takeaways

13. Key Countries Oncology Nutrition Analysis

    13.1. U.S.

        13.1.1. Pricing Analysis

        13.1.2. Market Share Analysis, 2021

            13.1.2.1. By Cancer Type

            13.1.2.2. By End-Use

    13.2. Canada

        13.2.1. Pricing Analysis

        13.2.2. Market Share Analysis, 2021

            13.2.2.1. By Cancer Type

            13.2.2.2. By End-Use

    13.3. Brazil

        13.3.1. Pricing Analysis

        13.3.2. Market Share Analysis, 2021

            13.3.2.1. By Cancer Type

            13.3.2.2. By End-Use

    13.4. Mexico

        13.4.1. Pricing Analysis

        13.4.2. Market Share Analysis, 2021

            13.4.2.1. By Cancer Type

            13.4.2.2. By End-Use

    13.5. Argentina

        13.5.1. Pricing Analysis

        13.5.2. Market Share Analysis, 2021

            13.5.2.1. By Cancer Type

            13.5.2.2. By End-Use

    13.6. Chile

        13.6.1. Pricing Analysis

        13.6.2. Market Share Analysis, 2021

            13.6.2.1. By Cancer Type

            13.6.2.2. By End-Use

    13.7. Peru

        13.7.1. Pricing Analysis

        13.7.2. Market Share Analysis, 2021

            13.7.2.1. By Cancer Type

            13.7.2.2. By End-Use

    13.8. Germany

        13.8.1. Pricing Analysis

        13.8.2. Market Share Analysis, 2021

            13.8.2.1. By Cancer Type

            13.8.2.2. By End-Use

    13.9. Italy

        13.9.1. Pricing Analysis

        13.9.2. Market Share Analysis, 2021

            13.9.2.1. By Cancer Type

            13.9.2.2. By End-Use

    13.10. France

        13.10.1. Pricing Analysis

        13.10.2. Market Share Analysis, 2021

            13.10.2.1. By Cancer Type

            13.10.2.2. By End-Use

    13.11. U.K.

        13.11.1. Pricing Analysis

        13.11.2. Market Share Analysis, 2021

            13.11.2.1. By Cancer Type

            13.11.2.2. By End-Use

    13.12. Spain

        13.12.1. Pricing Analysis

        13.12.2. Market Share Analysis, 2021

            13.12.2.1. By Cancer Type

            13.12.2.2. By End-Use

    13.13. Russia

        13.13.1. Pricing Analysis

        13.13.2. Market Share Analysis, 2021

            13.13.2.1. By Cancer Type

            13.13.2.2. By End-Use

    13.14. BENELUX

        13.14.1. Pricing Analysis

        13.14.2. Market Share Analysis, 2021

            13.14.2.1. By Cancer Type

            13.14.2.2. By End-Use

    13.15. China

        13.15.1. Pricing Analysis

        13.15.2. Market Share Analysis, 2021

            13.15.2.1. By Cancer Type

            13.15.2.2. By End-Use

    13.16. Japan

        13.16.1. Pricing Analysis

        13.16.2. Market Share Analysis, 2021

            13.16.2.1. By Cancer Type

            13.16.2.2. By End-Use

    13.17. South Korea

        13.17.1. Pricing Analysis

        13.17.2. Market Share Analysis, 2021

            13.17.2.1. By Cancer Type

            13.17.2.2. By End-Use

    13.18. GCC Countries

        13.18.1. Pricing Analysis

        13.18.2. Market Share Analysis, 2021

            13.18.2.1. By Cancer Type

            13.18.2.2. By End-Use

    13.19. South Africa

        13.19.1. Pricing Analysis

        13.19.2. Market Share Analysis, 2021

            13.19.2.1. By Cancer Type

            13.19.2.2. By End-Use

    13.20. Turkey

        13.20.1. Pricing Analysis

        13.20.2. Market Share Analysis, 2021

            13.20.2.1. By Cancer Type

            13.20.2.2. By End-Use

14. Market Structure Analysis

    14.1. Competition Dashboard

    14.2. Competition Benchmarking

    14.3. Market Share Analysis of Top Players

        14.3.1. By Regional

        14.3.2. By Cancer Type

        14.3.3. By End-Use

15. Competition Analysis

    15.1. Competition Deep Dive

        15.1.1. Abbott Laboratories

            15.1.1.1. Overview

            15.1.1.2. Product Portfolio

            15.1.1.3. Profitability by Market Segments

            15.1.1.4. Sales Footprint

            15.1.1.5. Strategy Overview

                15.1.1.5.1. Marketing Strategy

                15.1.1.5.2. Product Strategy

                15.1.1.5.3. Channel Strategy

        15.1.2. B. Braun Melsungen AG

            15.1.2.1. Overview

            15.1.2.2. Product Portfolio

            15.1.2.3. Profitability by Market Segments

            15.1.2.4. Sales Footprint

            15.1.2.5. Strategy Overview

                15.1.2.5.1. Marketing Strategy

                15.1.2.5.2. Product Strategy

                15.1.2.5.3. Channel Strategy

        15.1.3. Baxter International Inc.

            15.1.3.1. Overview

            15.1.3.2. Product Portfolio

            15.1.3.3. Profitability by Market Segments

            15.1.3.4. Sales Footprint

            15.1.3.5. Strategy Overview

                15.1.3.5.1. Marketing Strategy

                15.1.3.5.2. Product Strategy

                15.1.3.5.3. Channel Strategy

        15.1.4. Fresenius Kabi AG

            15.1.4.1. Overview

            15.1.4.2. Product Portfolio

            15.1.4.3. Profitability by Market Segments

            15.1.4.4. Sales Footprint

            15.1.4.5. Strategy Overview

                15.1.4.5.1. Marketing Strategy

                15.1.4.5.2. Product Strategy

                15.1.4.5.3. Channel Strategy

        15.1.5. Hormel Foods Corporation

            15.1.5.1. Overview

            15.1.5.2. Product Portfolio

            15.1.5.3. Profitability by Market Segments

            15.1.5.4. Sales Footprint

            15.1.5.5. Strategy Overview

                15.1.5.5.1. Marketing Strategy

                15.1.5.5.2. Product Strategy

                15.1.5.5.3. Channel Strategy

        15.1.6. Mead Johnson & Company LLC

            15.1.6.1. Overview

            15.1.6.2. Product Portfolio

            15.1.6.3. Profitability by Market Segments

            15.1.6.4. Sales Footprint

            15.1.6.5. Strategy Overview

                15.1.6.5.1. Marketing Strategy

                15.1.6.5.2. Product Strategy

                15.1.6.5.3. Channel Strategy

        15.1.7. Nestle S.A.

            15.1.7.1. Overview

            15.1.7.2. Product Portfolio

            15.1.7.3. Profitability by Market Segments

            15.1.7.4. Sales Footprint

            15.1.7.5. Strategy Overview

                15.1.7.5.1. Marketing Strategy

                15.1.7.5.2. Product Strategy

                15.1.7.5.3. Channel Strategy

        15.1.8. Pfizer Inc.

            15.1.8.1. Overview

            15.1.8.2. Product Portfolio

            15.1.8.3. Profitability by Market Segments

            15.1.8.4. Sales Footprint

            15.1.8.5. Strategy Overview

                15.1.8.5.1. Marketing Strategy

                15.1.8.5.2. Product Strategy

                15.1.8.5.3. Channel Strategy

16. Assumptions & Acronyms Used

17. Research Methodology

Customize this Report

Let us know your requirement to get
100% FREE customization

List of Tables

Table 1: Global Oncology Nutrition Value (US$ Bn) Forecast by Region, 2017-2032

Table 2: Global Oncology Nutrition Value (US$ Bn) Forecast by Cancer Type, 2017-2032

Table 3: Global Oncology Nutrition Value (US$ Bn) Forecast by End-Use, 2017-2032

Table 4: North America Oncology Nutrition Value (US$ Bn) Forecast by Country, 2017-2032

Table 5: North America Oncology Nutrition Value (US$ Bn) Forecast by Cancer Type, 2017-2032

Table 6: North America Oncology Nutrition Value (US$ Bn) Forecast by End-Use, 2017-2032

Table 7: Latin America Oncology Nutrition Value (US$ Bn) Forecast by Country, 2017-2032

Table 8: Latin America Oncology Nutrition Value (US$ Bn) Forecast by Cancer Type, 2017-2032

Table 9: Latin America Oncology Nutrition Value (US$ Bn) Forecast by End-Use, 2017-2032

Table 10: Europe Oncology Nutrition Value (US$ Bn) Forecast by Country, 2017-2032

Table 11: Europe Oncology Nutrition Value (US$ Bn) Forecast by Cancer Type, 2017-2032

Table 12: Europe Oncology Nutrition Value (US$ Bn) Forecast by End-Use, 2017-2032

Table 13: Asia Pacific Oncology Nutrition Value (US$ Bn) Forecast by Country, 2017-2032

Table 14: Asia Pacific Oncology Nutrition Value (US$ Bn) Forecast by Cancer Type, 2017-2032

Table 15: Asia Pacific Oncology Nutrition Value (US$ Bn) Forecast by End-Use, 2017-2032

Table 16: MEA Oncology Nutrition Value (US$ Bn) Forecast by Country, 2017-2032

Table 17: MEA Oncology Nutrition Value (US$ Bn) Forecast by Cancer Type, 2017-2032

Table 18: MEA Oncology Nutrition Value (US$ Bn) Forecast by End-Use, 2017-2032

Sabyasachi Ghosh
Principal Consultant
LinkedIn
Talk to Analyst

Find your sweet spots for generating winning opportunities in this market.

Talk to Analyst

List of Charts

Figure 1: Global Oncology Nutrition Value (US$ Bn) by Cancer Type, 2022-2032

Figure 2: Global Oncology Nutrition Value (US$ Bn) by End-Use, 2022-2032

Figure 3: Global Oncology Nutrition Value (US$ Bn) by Region, 2022-2032

Figure 4: Global Oncology Nutrition Value (US$ Bn) Analysis by Region, 2017-2032

Figure 5: Global Oncology Nutrition Value Share (%) and BPS Analysis by Region, 2022-2032

Figure 6: Global Oncology Nutrition Y-o-Y Growth (%) Projections by Region, 2022-2032

Figure 7: Global Oncology Nutrition Value (US$ Bn) Analysis by Cancer Type, 2017-2032

Figure 8: Global Oncology Nutrition Value Share (%) and BPS Analysis by Cancer Type, 2022-2032

Figure 9: Global Oncology Nutrition Y-o-Y Growth (%) Projections by Cancer Type, 2022-2032

Figure 10: Global Oncology Nutrition Value (US$ Bn) Analysis by End-Use, 2017-2032

Figure 11: Global Oncology Nutrition Value Share (%) and BPS Analysis by End-Use, 2022-2032

Figure 12: Global Oncology Nutrition Y-o-Y Growth (%) Projections by End-Use, 2022-2032

Figure 13: Global Oncology Nutrition Attractiveness by Cancer Type, 2022-2032

Figure 14: Global Oncology Nutrition Attractiveness by End-Use, 2022-2032

Figure 15: Global Oncology Nutrition Attractiveness by Region, 2022-2032

Figure 16: North America Oncology Nutrition Value (US$ Bn) by Cancer Type, 2022-2032

Figure 17: North America Oncology Nutrition Value (US$ Bn) by End-Use, 2022-2032

Figure 18: North America Oncology Nutrition Value (US$ Bn) by Country, 2022-2032

Figure 19: North America Oncology Nutrition Value (US$ Bn) Analysis by Country, 2017-2032

Figure 20: North America Oncology Nutrition Value Share (%) and BPS Analysis by Country, 2022-2032

Figure 21: North America Oncology Nutrition Y-o-Y Growth (%) Projections by Country, 2022-2032

Figure 22: North America Oncology Nutrition Value (US$ Bn) Analysis by Cancer Type, 2017-2032

Figure 23: North America Oncology Nutrition Value Share (%) and BPS Analysis by Cancer Type, 2022-2032

Figure 24: North America Oncology Nutrition Y-o-Y Growth (%) Projections by Cancer Type, 2022-2032

Figure 25: North America Oncology Nutrition Value (US$ Bn) Analysis by End-Use, 2017-2032

Figure 26: North America Oncology Nutrition Value Share (%) and BPS Analysis by End-Use, 2022-2032

Figure 27: North America Oncology Nutrition Y-o-Y Growth (%) Projections by End-Use, 2022-2032

Figure 28: North America Oncology Nutrition Attractiveness by Cancer Type, 2022-2032

Figure 29: North America Oncology Nutrition Attractiveness by End-Use, 2022-2032

Figure 30: North America Oncology Nutrition Attractiveness by Country, 2022-2032

Figure 31: Latin America Oncology Nutrition Value (US$ Bn) by Cancer Type, 2022-2032

Figure 32: Latin America Oncology Nutrition Value (US$ Bn) by End-Use, 2022-2032

Figure 33: Latin America Oncology Nutrition Value (US$ Bn) by Country, 2022-2032

Figure 34: Latin America Oncology Nutrition Value (US$ Bn) Analysis by Country, 2017-2032

Figure 35: Latin America Oncology Nutrition Value Share (%) and BPS Analysis by Country, 2022-2032

Figure 36: Latin America Oncology Nutrition Y-o-Y Growth (%) Projections by Country, 2022-2032

Figure 37: Latin America Oncology Nutrition Value (US$ Bn) Analysis by Cancer Type, 2017-2032

Figure 38: Latin America Oncology Nutrition Value Share (%) and BPS Analysis by Cancer Type, 2022-2032

Figure 39: Latin America Oncology Nutrition Y-o-Y Growth (%) Projections by Cancer Type, 2022-2032

Figure 40: Latin America Oncology Nutrition Value (US$ Bn) Analysis by End-Use, 2017-2032

Figure 41: Latin America Oncology Nutrition Value Share (%) and BPS Analysis by End-Use, 2022-2032

Figure 42: Latin America Oncology Nutrition Y-o-Y Growth (%) Projections by End-Use, 2022-2032

Figure 43: Latin America Oncology Nutrition Attractiveness by Cancer Type, 2022-2032

Figure 44: Latin America Oncology Nutrition Attractiveness by End-Use, 2022-2032

Figure 45: Latin America Oncology Nutrition Attractiveness by Country, 2022-2032

Figure 46: Europe Oncology Nutrition Value (US$ Bn) by Cancer Type, 2022-2032

Figure 47: Europe Oncology Nutrition Value (US$ Bn) by End-Use, 2022-2032

Figure 48: Europe Oncology Nutrition Value (US$ Bn) by Country, 2022-2032

Figure 49: Europe Oncology Nutrition Value (US$ Bn) Analysis by Country, 2017-2032

Figure 50: Europe Oncology Nutrition Value Share (%) and BPS Analysis by Country, 2022-2032

Figure 51: Europe Oncology Nutrition Y-o-Y Growth (%) Projections by Country, 2022-2032

Figure 52: Europe Oncology Nutrition Value (US$ Bn) Analysis by Cancer Type, 2017-2032

Figure 53: Europe Oncology Nutrition Value Share (%) and BPS Analysis by Cancer Type, 2022-2032

Figure 54: Europe Oncology Nutrition Y-o-Y Growth (%) Projections by Cancer Type, 2022-2032

Figure 55: Europe Oncology Nutrition Value (US$ Bn) Analysis by End-Use, 2017-2032

Figure 56: Europe Oncology Nutrition Value Share (%) and BPS Analysis by End-Use, 2022-2032

Figure 57: Europe Oncology Nutrition Y-o-Y Growth (%) Projections by End-Use, 2022-2032

Figure 58: Europe Oncology Nutrition Attractiveness by Cancer Type, 2022-2032

Figure 59: Europe Oncology Nutrition Attractiveness by End-Use, 2022-2032

Figure 60: Europe Oncology Nutrition Attractiveness by Country, 2022-2032

Figure 61: Asia Pacific Oncology Nutrition Value (US$ Bn) by Cancer Type, 2022-2032

Figure 62: Asia Pacific Oncology Nutrition Value (US$ Bn) by End-Use, 2022-2032

Figure 63: Asia Pacific Oncology Nutrition Value (US$ Bn) by Country, 2022-2032

Figure 64: Asia Pacific Oncology Nutrition Value (US$ Bn) Analysis by Country, 2017-2032

Figure 65: Asia Pacific Oncology Nutrition Value Share (%) and BPS Analysis by Country, 2022-2032

Figure 66: Asia Pacific Oncology Nutrition Y-o-Y Growth (%) Projections by Country, 2022-2032

Figure 67: Asia Pacific Oncology Nutrition Value (US$ Bn) Analysis by Cancer Type, 2017-2032

Figure 68: Asia Pacific Oncology Nutrition Value Share (%) and BPS Analysis by Cancer Type, 2022-2032

Figure 69: Asia Pacific Oncology Nutrition Y-o-Y Growth (%) Projections by Cancer Type, 2022-2032

Figure 70: Asia Pacific Oncology Nutrition Value (US$ Bn) Analysis by End-Use, 2017-2032

Figure 71: Asia Pacific Oncology Nutrition Value Share (%) and BPS Analysis by End-Use, 2022-2032

Figure 72: Asia Pacific Oncology Nutrition Y-o-Y Growth (%) Projections by End-Use, 2022-2032

Figure 73: Asia Pacific Oncology Nutrition Attractiveness by Cancer Type, 2022-2032

Figure 74: Asia Pacific Oncology Nutrition Attractiveness by End-Use, 2022-2032

Figure 75: Asia Pacific Oncology Nutrition Attractiveness by Country, 2022-2032

Figure 76: MEA Oncology Nutrition Value (US$ Bn) by Cancer Type, 2022-2032

Figure 77: MEA Oncology Nutrition Value (US$ Bn) by End-Use, 2022-2032

Figure 78: MEA Oncology Nutrition Value (US$ Bn) by Country, 2022-2032

Figure 79: MEA Oncology Nutrition Value (US$ Bn) Analysis by Country, 2017-2032

Figure 80: MEA Oncology Nutrition Value Share (%) and BPS Analysis by Country, 2022-2032

Figure 81: MEA Oncology Nutrition Y-o-Y Growth (%) Projections by Country, 2022-2032

Figure 82: MEA Oncology Nutrition Value (US$ Bn) Analysis by Cancer Type, 2017-2032

Figure 83: MEA Oncology Nutrition Value Share (%) and BPS Analysis by Cancer Type, 2022-2032

Figure 84: MEA Oncology Nutrition Y-o-Y Growth (%) Projections by Cancer Type, 2022-2032

Figure 85: MEA Oncology Nutrition Value (US$ Bn) Analysis by End-Use, 2017-2032

Figure 86: MEA Oncology Nutrition Value Share (%) and BPS Analysis by End-Use, 2022-2032

Figure 87: MEA Oncology Nutrition Y-o-Y Growth (%) Projections by End-Use, 2022-2032

Figure 88: MEA Oncology Nutrition Attractiveness by Cancer Type, 2022-2032

Figure 89: MEA Oncology Nutrition Attractiveness by End-Use, 2022-2032

Figure 90: MEA Oncology Nutrition Attractiveness by Country, 2022-2032

Need specific information?

Request Customization

Explore Healthcare Insights

View Reports

Recommendations

Healthcare

Oncology Blood Testing Market

Published : March 2018

Healthcare

Oncology Adjuvants Market

Published : June 2017

Healthcare

Oncology Apoptosis Modulators Market

Published : April 2016

Google translate

Oncology Nutrition Market